Comparison and trend analysis of cancer incidence in China and globally in 2022

Table 1 Estimated numbers of new cancer cases and cancer incidence rates in China and globally in 2022

Cancer sites	ICD-10	Chinese cancer incidence			Global cancer incidence
		Rank	Cases (× 104)	% of all sites	Rank	Cases (× 104)	% of all sites
Lung	C33–34	1	106.06	21.98	1	248.03	12.42
Colon-rectum	C18–21	2	51.71	10.72	3	192.61	9.65
Thyroid	C73	3	46.61	9.66	7	82.12	4.11
Liver	C22	4	36.77	7.62	6	86.53	4.33
Stomach	C16	5	35.87	7.43	5	96.84	4.85
Female breast	C50	6	35.72	7.40	2	230.89	11.56
Esophagus	C15	7	22.40	4.64	12	51.07	2.56
Cervix	C53	8	15.07	3.12	8	66.10	3.31
Prostate	C61	9	13.42	2.78	4	146.67	7.35
Pancreas	C25	10	11.87	2.46	13	51.06	2.56
Bladder	C67	11	9.29	1.93	10	61.38	3.07
Brain, central nervous system	C70–72	12	8.75	1.81	19	32.15	1.61
Lymphoma	C81–86, 88	13	8.52	1.77	9	63.54	3.18
Leukemia	C91–95	14	8.19	1.70	14	48.68	2.44
Uterus	C54	15	7.77	1.61	16	42.02	2.10
Kidney	C64	16	7.37	1.53	15	43.44	2.18
Lip, oral cavity & pharynx	C00–10, 12–13	17	6.51	1.35	11	58.21	2.92
Ovary	C56	18	6.11	1.27	18	32.44	1.62
Nasopharynx	C11	19	5.10	1.06	22	12.04	0.60
Gallbladder	C23	20	3.11	0.64	21	12.25	0.61
Larynx	C32	21	2.95	0.61	20	18.90	0.95
Melanoma of skin	C43	22	0.88	0.18	17	33.16	1.66
Testis	C62	23	0.35	0.07	23	7.20	0.36
All other sites1	Other		31.69			279.16
All sites1	All		482.47			1996.48

¹Non-melanoma skin cancer (C44) was included.

ICD-10: International Statistical Classification of Diseases and Related Health Problems 10^th Revision.